Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome Unresponsive to 8 Weeks of High Dose Prednisone

NCT03298698 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT03298698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03298698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome Unresponsive to 8 Weeks of High Dose Prednisone
Lead sponsor
Radboud University Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
August 22, 2018
Completion date
January 22, 2022
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

focal segmental glomerulosclerosis, idiopathic nephrotic syndrome, minimal change disease